124 related articles for article (PubMed ID: 15486466)
41. Apolipoprotein E favours the blunting by high-fat diet of prostacyclin receptor activation in the mouse aorta.
Cheng Y; Vanhoutte PM; Leung SWS
Br J Pharmacol; 2018 Sep; 175(17):3453-3469. PubMed ID: 29859010
[TBL] [Abstract][Full Text] [Related]
42. The relative atherogenicity of VLDL and LDL is dependent on the topographic site.
Van Craeyveld E; Jacobs F; Feng Y; Thomassen LC; Martens JA; Lievens J; Snoeys J; De Geest B
J Lipid Res; 2010 Jun; 51(6):1478-85. PubMed ID: 20086185
[TBL] [Abstract][Full Text] [Related]
43. Anti-inflammatory and recycling properties of an apolipoprotein mimetic peptide, Ac-hE18A-NH(2).
Datta G; White CR; Dashti N; Chaddha M; Palgunachari MN; Gupta H; Handattu SP; Garber DW; Anantharamaiah GM
Atherosclerosis; 2010 Jan; 208(1):134-41. PubMed ID: 19656510
[TBL] [Abstract][Full Text] [Related]
44. Apolipoprotein E-induced cell signaling in the vessel wall.
Hui DY
Rev Endocr Metab Disord; 2004 Dec; 5(4):335-41. PubMed ID: 15486466
[No Abstract] [Full Text] [Related]
45. Overexpression of lectin-like oxidized low-density lipoprotein receptor-1 induces intramyocardial vasculopathy in apolipoprotein E-null mice.
Inoue K; Arai Y; Kurihara H; Kita T; Sawamura T
Circ Res; 2005 Jul; 97(2):176-84. PubMed ID: 15961718
[TBL] [Abstract][Full Text] [Related]
46. [Novel lipoprotein receptor functions].
May P
Dtsch Med Wochenschr; 2006 Jun; 131(23):1328-31. PubMed ID: 16761203
[No Abstract] [Full Text] [Related]
47. Apolipoprotein E receptors: linking brain development and Alzheimer's disease.
Herz J; Beffert U
Nat Rev Neurosci; 2000 Oct; 1(1):51-8. PubMed ID: 11252768
[TBL] [Abstract][Full Text] [Related]
48. [Apolipoprotein E].
Xie YH; Wang KQ
Sheng Li Ke Xue Jin Zhan; 1985 Apr; 16(2):136-41. PubMed ID: 2990024
[No Abstract] [Full Text] [Related]
49. [Lipid metabolism in the central nervous system and neurodegenerative diseases].
Hayashi H
Nihon Yakurigaku Zasshi; 2011 Jun; 137(6):227-31. PubMed ID: 21666340
[No Abstract] [Full Text] [Related]
50. Vascular apolipoprotein e expression and recruitment from circulation to modulate smooth muscle cell response to endothelial denudation.
Moore ZW; Zhu B; Kuhel DG; Hui DY
Am J Pathol; 2004 Jun; 164(6):2109-16. PubMed ID: 15161645
[TBL] [Abstract][Full Text] [Related]
51. Lipoprotein receptors in the vascular wall.
Herz J; Hui DY
Curr Opin Lipidol; 2004 Apr; 15(2):175-81. PubMed ID: 15017360
[TBL] [Abstract][Full Text] [Related]
52. Antimitogenic effects of HDL and APOE mediated by Cox-2-dependent IP activation.
Kothapalli D; Fuki I; Ali K; Stewart SA; Zhao L; Yahil R; Kwiatkowski D; Hawthorne EA; FitzGerald GA; Phillips MC; Lund-Katz S; Puré E; Rader DJ; Assoian RK
J Clin Invest; 2004 Feb; 113(4):609-18. PubMed ID: 14966570
[TBL] [Abstract][Full Text] [Related]
53. Hepatic catabolism of remnant lipoproteins: where the action is.
Havel RJ; Hamilton RL
Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):213-5. PubMed ID: 14766735
[No Abstract] [Full Text] [Related]
54. Functions of lipoprotein receptors in neurons.
Beffert U; Stolt PC; Herz J
J Lipid Res; 2004 Mar; 45(3):403-9. PubMed ID: 14657206
[TBL] [Abstract][Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
